Edition:
India

Paion AG (PA8G.DE)

PA8G.DE on Xetra

2.23EUR
16 Nov 2018
Change (% chg)

€0.05 (+2.06%)
Prev Close
€2.18
Open
€2.17
Day's High
€2.35
Day's Low
€2.16
Volume
104,911
Avg. Vol
52,707
52-wk High
€2.78
52-wk Low
€1.91

Chart for

About

Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In... (more)

Overall

Beta: 0.77
Market Cap(Mil.): €162.82
Shares Outstanding(Mil.): 61.12
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates